MiRNA-based therapy for pulmonary hypertension: MiRNA-129-2 suppresses pulmonary hypertension via down regulation of its target gene, 22/March/2015, 13.38

Molecular therapy for Myocardial infarction: Snail inhibits myocardial infarction by enhancing autophagy proteins Atg12 and Beclin 1, 22/May/2015, 11.38 am
May 22, 2015
Natural product-based Lifespan extension therapy: Antrodia salmonea, a traditional chinese medicine, prolongs mammalian life span via down regulation of angiotensin II type I receptor (AT1R), 22/May/2015, 13.58
May 22, 2015
Show all

A recent study from the from the Department of Surgery, University of Pittsburgh School of Medicine, Pittsburgh, United States of America shows that “High mobility group box 1 contributes to the pathogenesis of experimental pulmonary hypertension via activation of Toll-like receptor 4. This study was published in the 8 Feb’13  issue of the Journal “Molecular Medicine”  by Drs. Bauer PMBauer EM and others.

On the foundation of this interesting finding, Dr L Boominathan PhD, Director-cum-chief Scientist of GBMD, reports that: MiRNA-based therapy for pulmonary hypertension: MiRNA-129-2  suppresses pulmonary hypertension via down regulation of its target gene. This study suggests, for the first time, that MiRNA-129-2, by decreasing the expression of its target gene, may: (1) decrease Right ventricular systolic pressure, and (2) inhibit thickening of the pulmonary artery wall. Together, pharmacological formulations encompassing “MiRNA-129-2  or its activators may be used to treat patients suffering from pulmonary hypertension.

Idea Proposed/Formulated byDr L Boominathan Ph.D.

Web: http://genomediscovery.org

Terms & Conditions apply http://genomediscovery.org/registration/terms-and-conditions/

To citeBoominathan,  MiRNA-based therapy for pulmonary hypertension: MiRNA–129-2 suppresses pulmonary hypertension via down regulation of its target gene, 22/March/2015,  13.38,  Genome-2-Bio-Medicine Discovery center (GBMD), http://genomediscovery.org

Courtesy: When you cite drop us a line at info@genomediscovery.org

* Research cooperation

Undisclosed information: How MiRNA-129-2  stifles pulmonary hypertension

Comments are closed.